How The Intuitive Surgical (ISRG) Story Is Shifting With Dv5, FDA Clears, And Valuation Jitters

Simply Wall St

Mon, February 23, 2026 at 4:09 PM GMT+9 3 min read

In this article:

ISRG

Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge.

Intuitive Surgical’s fair value estimate has been updated to US$611.82 per share from US$596.36, a move of about 2.6% that reflects a refined view of the company’s long term setup. Behind this shift, recent analyst research points to a split narrative, with some highlighting the Dv5 rollout, procedure trends, and sector conditions into 2026, while others focus on valuation, sector rotation risk, and policy headlines. In the sections that follow, you will see how these moving pieces fit together and how to track the evolving story around Intuitive Surgical.

Analyst Price Targets don’t always capture the full story. Head over to our Company Report to find new ways to value Intuitive Surgical.

What Wall Street Has Been Saying

🐂 Bullish Takeaways

Goldman Sachs lifted its price target to US$714 from US$621, and Barclays moved to US$686 from US$635, signaling that some firms see room for the shares to support higher valuation multiples.

BTIG raised its target to US$616 from US$589 and highlights the Dv5 launch as a key contributor to modeled FY26 and FY27 revenue, pointing to both system sales and Instruments & Accessories as important drivers.

Bernstein increased its target to US$740 from US$700 and links its view to improving sentiment toward U.S. healthcare stocks as policy and macro questions become clearer.

Evercore ISI references survey work indicating healthy procedure and CapEx trends into 2026, which it sees as supportive for MedTech tools companies such as Intuitive Surgical.

🐻 Bearish Takeaways

Citi cut its price target by US$45, and Evercore ISI flags sector rotation risk as well as potential ACA and Medicare policy changes, which some investors may view as pressure points for valuation.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there’s more to the story. Head to the Simply Wall St Community to discover more perspectives!

NasdaqGS:ISRG 1-Year Stock Price Chart

See how Intuitive Surgical’s fair value stacks up across multiple valuation models — not just analyst targets.

How This Changes the Fair Value For Intuitive Surgical

Fair value updated to US$611.82 per share from US$596.36 per share, a change of about 2.6%.

Revenue growth assumption updated to 13.83% from 13.47%.

Net profit margin revised to 29.31% from 30.34%.

Future P/E updated to 60.56x from 60.81x.

Discount rate adjusted to 7.67% from 7.68%.

Never Miss an Update: Follow The Narrative

Narratives link a company’s real world story, like product rollouts and policy changes, to a financial forecast and fair value. They update as new data, guidance, and research come through so you can see how the thesis is evolving.

Story Continues  

Head over to the Simply Wall St Community and follow the Narrative on Intuitive Surgical to stay up to date on:

How expanding global procedure volumes, a growing installed base, and higher system utilization tie into recurring revenue and margin stability.

The role of da Vinci 5, a broader procedure mix, and digital tools in supporting future procedure growth and instrument and accessory usage.

Key risks such as international budget constraints, trade and tariff pressures, competition in instruments, and evolving reimbursement and regulatory policy.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include ISRG.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email [email protected]_

Terms and Privacy Policy

Privacy Dashboard

More Info